BIP
GSK icon

Brandes Investment Partners’s GSK GSK Stock Holding History

Brandes Investment Partners’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$80.2M Sell
1,453,002
-271,574
-16% -$14.7M 0.57% 64
2025
Q4 		$84.6M Sell
1,724,576
-143,428
-8% -$6.69M 0.64% 57
2025
Q3 		$80.6M Buy
1,868,004
+100,569
+6% +$3.93M 0.65% 57
2025
Q2 		$67.9M Buy
1,767,435
+87,547
+5% +$3.35M 0.61% 55
2025
Q1 		$65.1M Buy
1,679,888
+318,679
+23% +$11.7M 0.66% 55
2024
Q4 		$46M Buy
1,361,209
+283,352
+26% +$10.2M 0.51% 66
2024
Q3 		$44.1M Sell
1,077,857
-67,655
-6% -$2.77M 0.5% 66
2024
Q2 		$44.2M Buy
1,145,512
+61,099
+6% +$2.57M 0.54% 62
2024
Q1 		$46.5M Buy
1,084,413
+19,080
+2% +$787K 0.6% 56
2023
Q4 		$39.5M Buy
1,065,333
+381,698
+56% +$13.7M 0.6% 57
2023
Q3 		$24.8M Buy
683,635
+33,143
+5% +$1.18M 0.48% 66
2023
Q2 		$23.2M Buy
650,492
+8,649
+1% +$310K 0.47% 64
2023
Q1 		$22.8M Buy
641,843
+620,455
+2,901% +$21.7M 0.48% 62
2022
Q4 		$752K Sell
21,388
-572,391
-96% -$19.1M 0.02% 116
2022
Q3 		$17.5M Buy
593,779
+26,075
+5% +$988K 0.46% 62
2022
Q2 		$30.9M Sell
567,704
-72,614
-11% -$4.01M 0.75% 41
2022
Q1 		$34.9M Sell
640,318
-51,595
-7% -$2.8M 0.75% 41
2021
Q4 		$38.1M Sell
691,913
-4,479
-0.6% -$233K 0.83% 39
2021
Q3 		$33.3M Sell
696,392
-19,876
-3% -$998K 0.72% 46
2021
Q2 		$35.7M Buy
716,268
+24,046
+3% +$1.16M 0.79% 42
2021
Q1 		$31.5M Buy
692,222
+84,892
+14% +$3.85M 0.74% 45
2020
Q4 		$28.1M Buy
607,330
+25,084
+4% +$1.15M 0.72% 50
2020
Q3 		$27.4M Sell
582,246
-168,927
-22% -$8.46M 0.95% 38
2020
Q2 		$38.3M Sell
751,173
-247,821
-25% -$12.7M 1.17% 30
2020
Q1 		$47.3M Sell
998,994
-207,712
-17% -$11.1M 1.66% 17
2019
Q4 		$70.9M Sell
1,206,706
-83,050
-6% -$4.62M 1.69% 17
2019
Q3 		$68.8M Sell
1,289,756
-193,614
-13% -$9.96M 1.78% 15
2019
Q2 		$74.2M Sell
1,483,370
-184,948
-11% -$9.28M 1.65% 17
2019
Q1 		$87.1M Buy
1,668,318
+34,124
+2% +$1.71M 2.03% 15
2018
Q4 		$78.1M Sell
1,634,194
-165,048
-9% -$8.13M 1.99% 15
2018
Q3 		$90.3M Sell
1,799,242
-76,538
-4% -$3.89M 2.04% 14
2018
Q2 		$94.5M Sell
1,875,780
-35,791
-2% -$1.8M 2.13% 14
2018
Q1 		$93.4M Buy
1,911,571
+101,214
+6% +$4.71M 1.99% 14
2017
Q4 		$80.3M Buy
1,810,357
+104,146
+6% +$4.81M 1.62% 20
2017
Q3 		$86.6M Sell
1,706,211
-982,866
-37% -$49.9M 1.76% 16
2017
Q2 		$145M Sell
2,689,077
-1,953
-0.1% -$104K 2.29% 12
2017
Q1 		$142M Buy
2,691,030
+171,333
+7% +$8.69M 2.11% 17
2016
Q4 		$121M Sell
2,519,697
-300,837
-11% -$14.9M 1.82% 22
2016
Q3 		$152M Sell
2,820,534
-559,071
-17% -$30.7M 2.28% 11
2016
Q2 		$183M Sell
3,379,605
-199,922
-6% -$10.5M 2.8% 7
2016
Q1 		$181M Buy
3,579,527
+137,103
+4% +$6.83M 2.6% 6
2015
Q4 		$174M Sell
3,442,424
-296,042
-8% -$15.1M 2.54% 9
2015
Q3 		$180M Buy
3,738,466
+287,568
+8% +$15M 2.63% 8
2015
Q2 		$180M Buy
3,450,898
+347,640
+11% +$19.6M 2.3% 10
2015
Q1 		$179M Buy
3,103,258
+477,834
+18% +$27.4M 2.46% 8
2014
Q4 		$140M Sell
2,625,424
-107,150
-4% -$5.99M 1.98% 18
2014
Q3 		$157M Buy
2,732,574
+732,536
+37% +$44.9M 2.08% 14
2014
Q2 		$134M Buy
2,000,038
+268,645
+16% +$18.2M 1.62% 28
2014
Q1 		$116M Buy
1,731,393
+15,024
+0.9% +$1.02M 1.46% 29
2013
Q4 		$115M Buy
1,716,369
+198,998
+13% +$12.9M 1.41% 30
2013
Q3 		$95.2M Sell
1,517,371
-28,179
-2% -$1.81M 1.22% 33
2013
Q2 		$96.5M Buy
+1,545,550
New +$98.1M 1.21% 32

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Brandes Investment Partners's GSK Position: Q1 2026 in Review

Brandes Investment Partners reduced its GSK (GSK) stake by 16% in Q1 2026, selling an estimated $14.7M and leaving 1,453,002 shares worth $80.2M. The position accounts for 0.57% of the portfolio, ranked #64.

Brandes Investment Partners first reported a position in GSK in Q2 2013 and has held it in 52 quarters since. The position peaked at $183M in Q2 2016. 1,032 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Brandes Investment Partners held 1,453,002 shares of GSK worth $80.2M as of Q1 2026.
  • Brandes Investment Partners sold 271,574 GSK shares in Q1 2026, an estimated $14.7M.
  • GSK made up 0.57% of Brandes Investment Partners's portfolio in Q1 2026, its #64 holding.
  • Brandes Investment Partners first reported a position in GSK in Q2 2013 and has held it in 52 quarters since.
  • Brandes Investment Partners's GSK position peaked at $183M in Q2 2016.
  • 1,032 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Brandes Investment Partners's 13F filing for Q1 2026, filed 15 May 2026.